Search
Selected: All

IL-16 antagonist peptides and DNA encoding the peptides

Drug – bio-affecting and body treating compositions – Lymphokine – Interleukin
Reexamination Certificate

  [ 0.00 ] – not rated yet Voters 0   Comments 0

IL-16 antagonist peptides and DNA encoding the peptides

Drug – bio-affecting and body treating compositions – Lymphokine – Interleukin
Reexamination Certificate

  [ 0.00 ] – not rated yet Voters 0   Comments 0

IL-17 related mammalian cytokine polypeptides (IL-17E)

Drug – bio-affecting and body treating compositions – Lymphokine – Interleukin
Reexamination Certificate

  [ 0.00 ] – not rated yet Voters 0   Comments 0

IL-17C related mammalian cytokine polypeptides

Drug – bio-affecting and body treating compositions – Lymphokine – Interleukin
Reexamination Certificate

  [ 0.00 ] – not rated yet Voters 0   Comments 0

IL-18/IGIF chemotherapeutic compositions

Drug – bio-affecting and body treating compositions – Lymphokine – Interleukin
Reexamination Certificate

  [ 0.00 ] – not rated yet Voters 0   Comments 0

IL-2 selective agonists and antagonists

Drug – bio-affecting and body treating compositions – Lymphokine – Interleukin
Reexamination Certificate

  [ 0.00 ] – not rated yet Voters 0   Comments 0

IL-21 variants

Drug – bio-affecting and body treating compositions – Lymphokine – Interleukin
Reexamination Certificate

  [ 0.00 ] – not rated yet Voters 0   Comments 0

IL-4 and IL-10 to downregulate delayed-type hypersensitivity and

Drug – bio-affecting and body treating compositions – Lymphokine – Interleukin
Patent

  [ 0.00 ] – not rated yet Voters 0   Comments 0

IL-4 receptor for the therapy, prophylaxis and diagnosis of...

Drug – bio-affecting and body treating compositions – Lymphokine – Interleukin
Reexamination Certificate

  [ 0.00 ] – not rated yet Voters 0   Comments 0

IL-6 as serum uric acid decreasing compound

Drug – bio-affecting and body treating compositions – Lymphokine – Interleukin
Patent

  [ 0.00 ] – not rated yet Voters 0   Comments 0

IL-7 to stimulate platelet production

Drug – bio-affecting and body treating compositions – Lymphokine – Interleukin
Patent

  [ 0.00 ] – not rated yet Voters 0   Comments 0

IL1-β Binding antibodies and fragments thereof

Drug – bio-affecting and body treating compositions – Lymphokine – Interleukin
Reexamination Certificate

  [ 0.00 ] – not rated yet Voters 0   Comments 0

IL13 mutants

Drug – bio-affecting and body treating compositions – Lymphokine – Interleukin
Reexamination Certificate

  [ 0.00 ] – not rated yet Voters 0   Comments 0

IL6RIL6 chimera for the treatment of neurodegenerative diseases

Drug – bio-affecting and body treating compositions – Lymphokine – Interleukin
Reexamination Certificate

  [ 0.00 ] – not rated yet Voters 0   Comments 0

IL8 inhibitors

Drug – bio-affecting and body treating compositions – Lymphokine – Interleukin
Reexamination Certificate

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Immunologic enhancement with intermittent interleukin-2 therapy

Drug – bio-affecting and body treating compositions – Lymphokine – Interleukin
Reexamination Certificate

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Immunologic enhancement with intermittent interleukin-2 therapy

Drug – bio-affecting and body treating compositions – Lymphokine – Interleukin
Reexamination Certificate

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Immunologic enhancement with intermittent interleukin-2 therapy

Drug – bio-affecting and body treating compositions – Lymphokine – Interleukin
Patent

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Immunomodulators

Drug – bio-affecting and body treating compositions – Lymphokine – Interleukin
Reexamination Certificate

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Immunopotentiating protocol for chemotherapy-responsive tumors

Drug – bio-affecting and body treating compositions – Lymphokine – Interleukin
Patent

  [ 0.00 ] – not rated yet Voters 0   Comments 0
  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.